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IDNEY FIBROSIS is a major factor related to chronic graft loss. Currently the diagnosis of interstitial fibrosis and tubular atrophy (IF/TA) depends on the analysis of graft biopsies. 1 The development of noninvasive biomarkers would be important for better graft monitoring. Kidney injury molecule-1 (KIM-1) is a protein present in toxic and ischemic acute renal injury and in chronic kidney diseases. [2] [3] [4] In this study, we evaluated the messenger (mRNA) transcription and gene expression of KIM-1 in kidney tissue and in urinary sediment cells (USC) of kidney transplant patients with graft dysfunction.
PATIENTS AND METHODS
Seventy-seven kidney transplant recipients who undertook an indication graft biopsy between January 2008 and December 2009 were included. At each biopsy one-third of a core was immediately frozen in liquid nitrogen for later molecular analyses. Urine samples were obtained immediately before biopsy: USC were isolated and frozen until RNA extraction. Pathological analyzes were performed according to the Banff 2007 classification. 1 The biopsies were classified in four diagnostic groups: (1) acute tubular necrosis (ATN, n ϭ 9); (2) acute rejection (AR, n ϭ 49); (3) acute calcineurin inhibitors nephrotoxicity (CIN, n ϭ 10); and (4) IFTA, (n ϭ 29). Tissue and USC RNA was extracted, reversed transcribed, and amplified by real-time polymerase chain reaction polymerase (TaqMan, ABI-PRISM 7000 SDS, Applied Biosystems) using specific primers (HAVCR-1, Applied Biosystems) for the KIM-1 gene and 18s rRNA as an endogenous control. The analysis of the amplified products were performed by the relative quantification method 2
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. Data are presented as means Ϯ standard deviations and medians and percertiles (P25-75) values. Multiple comparisons where made by Tukey test, and nonparametric data was analyzed by Kruskal-Wallis test. P levels lower than .05 were considered statistically significant.
RESULTS
Patients were predominantly males (79%), Caucasians (87%), and 78% received grafts from deceased donors. A significantly higher serum creatinine, at the day of the biopsy, was observed in the ATN group (6.4 Ϯ 1.9 mg/dL) as compared to the patients classified in the CIN (2.0 Ϯ 0.71 mg/dL) and IF/TA groups (3.5 Ϯ 1.6 mg/dL; P Ͻ .05). The group with AR (4.5 Ϯ 2.3 mg/dL) also presented higher serum creatinine as compared to the CIN group (P Ͻ .05). Cold ischemia time was significantly higher in the ATN group (23.6 Ϯ 5.7 hours) as compared to the CIN group (13.3 Ϯ 9.6 hours; P Ͻ .05). Time interval between the transplant surgery and graft biopsy was higher in the IF/TA group (672; 242-1752 days) as compared to other groups (P Ͻ .05). 
DISCUSSION
KIM-1 is a type I transmembrane gl coprotein with immunoglobulin and by mucin domains the extra-cellular portion. The cytoplasmic domain is relatively short and has a potentially phosphorilated site, indicating that KIM-1 is perhaps involved in molecular signaling. The ectodomain is cleaved by a metalloproteinase and released in urine. 5, 6 KIM-1 expression in dedifferentiated tubular epithelium suggests that this protein is involved in the processes of tubular fibrosis and may also play a role as a biomarker for proliferation in regenerative mechanisms. 7 We have previously shown increased KIM-1 mRNA transcription in biopsies of kidney transplant recipients with IF/TA and chronic CIN. In this study, we confirmed our previous findings in another cohort and expanded by showing it is also significantly increased in UCS. 8 These data suggest that USC KIM-1 mRNA quantification may be used as a noninvasive biomarker of fibrosis in kidney grafts with IF/TA. 
